
MV140, a sublingual polyvalent bacterial preparation to treat recurrent urinary tract infections, licenses human dendritic cells for generating Th1, Th17, and IL-10 responses via Syk and MyD88
Benito-Villalvilla, C, Cirauqui, C, Diez-Rivero, C M, Casanovas, M, Subiza, J L, Palomares, OLangue:
english
Journal:
Mucosal Immunology
DOI:
10.1038/mi.2016.112
Date:
December, 2016
Fichier:
PDF, 2.09 MB
english, 2016